BioCardia, Inc. Common Stock (BCDA) is a publicly traded Healthcare sector company. As of August 26, 2026, BCDA trades at $1.12 with a market cap of $16.05M and a P/E ratio of -0.91. BCDA moved -1.33% today. Year to date, BCDA is -11.02%; over the trailing twelve months it is -42.05%. Its 52-week range spans $0.75 to $3.20. Analyst consensus is buy with an average price target of $25.00. Rallies surfaces BCDA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks hedge fund and 13F ownership for BCDA, including fund holders, share counts, and position changes when data is available.
| Metric | Value |
|---|---|
| Price | $1.12 |
| Market Cap | $16.05M |
| P/E Ratio | -0.91 |
| EPS | $-1.23 |
| Dividend Yield | 0.00% |
| 52-Week High | $3.20 |
| 52-Week Low | $0.75 |
| Volume | 1.46K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-8.23M |
| Gross Margin | 0.00% |
1 analysts cover BCDA: 0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $25.00.